CardiologyOnline
News
Drugs
Xagena Medicine
Xagena.net
Atrial fibrillation, Amiodarone more efficacy than Sotalol for maintaining sinus rhythm
ACAT2, a new target for atherosclerosis
Antibiotics fail to prevent coronary events
Fish and soil oil may protect against heart attacks
Hypertension, diuretics work better than newer therapies
Folate intake associated with hypertension in women
Coronary heart disease, high-versus low dose Atorvastatin
Obstructive sleep apnea and risk of sudden death from cardiac causes
Nesiritide increases the risk of worsening renal function in patients with ADHF
BNP is a strong prognostic indicator in patients with heart failure
Aliskiren, a novel renin inhibitor in hypertension
Vitamin E can increase the risk for heart failure
Addition of Clopidogrel to Aspirin and fibrinolytic therapy proves beneficial for myocardial infarction
Drug-eluting stent: Cypher and Taxus, comparable efficacy in preventing in-segment binary restenosis
Dietary fiber intake reduces blood pressure in patients with hypertension
FDA: Crestor, favorable risk/benefit ratio
FDA has approved Candesartan Cilexetil for the treatment of heart failure
Treatment of systolic hypertension in older patients with SBP of at least 160 mm Hg is supported by strong evidence
A to Z Trial , Z phase : Simvastatin did not achieve the prespecified end point
ACTION trial : addition of Nifedipine GITS to conventional treatment of angina pectoris has no effect on major cardiovascular event-free survival
Next Pages
«
Web
Xagena News
Link
•
Allergology
•
Andrology
•
Biomedicine
•
Cardiology
•
Dermatology
•
Diabetology
•
Diagnostics
•
Drugs
•
Endocrinology
•
Gastroenterology
•
Gene Medicine
•
Gynecology
•
Hematology
•
Hepatology
•
Infectivology
•
Metabolism
•
Nephrology
•
Neurology
•
Oncology
•
Ophthalmology
•
Pediatrics
•
Pharmacology
•
Pneumology
•
Psychiatry
•
Rheumatology
•
Stem Therapy
•
Urology
•
Vaccines
•
Virology
n
Xagena.it
Powered by Luca Malattia -
LM Web Solutions